Click “Subscribe Now” to get attorney insights on the latest developments in a range of services and industries.
Where science converges with evolving consciousness, culture, and law.
With increasing recognition that certain psychedelic substances have therapeutic value in treating a variety of medical conditions, psychedelics are emerging in a complex and highly regulated environment. As the industry proceeds toward state decriminalization and legalization, the FDA is already making critical decisions regarding product safety and regulation.
Dickinson Wright’s psychedelics law team provides comprehensive legal counsel to product developers, clinicians, financial institutions, investors, and other business entities, enabling them to explore the potential application of psychedelics while thriving in this complicated and highly regulated market. Clients benefit from our ability to strategize throughout the entire lifecycle of a project, including research, development, funding, and commercialization.